Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
28 participants
INTERVENTIONAL
2011-03-31
2011-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Secondary objectives of the study are to evaluate the effect of salt consumption on blood pressure among the subjects who are hypertensive and obese and normal according to body mass index and to evaluate the effect of salt consumption on renin activity in hypertensive subjects.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Significance of Sodium Balance and the Value of Salt-blood Test in Identifying Salt Sensitive Patients
NCT05165823
Effect of no Added Salt Diet on Urinary Sodium and Blood Pressure
NCT00491881
A Community Health Worker-Led LSSS Intervention in Bangladesh
NCT05425030
Inflammatory Response to Salt in Essential Hypertension
NCT01665534
Comparison on Blood Pressure Effect of an Equivalent Sodium Intake, With Different Nature, for Hypertensive Subjects
NCT05108402
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
At the beginning of the study, information such as demographic, family story, medical story, diet habits, concomitant medication and physical measurements (height, weight and waist circumference) were received from the subjects.
24 hour blood pressure of the subjects is measured for four times, before the beginning of diet specific to their groups, at the end of the 3-week diet, before the beginning of the second diet and at the end of their second diet. The subjects were asked for collecting 24-h urine in the same days of blood pressure measurement. Sodium, potassium, urea, creatinin and microalbumin measurements were measured in the collected urine. Blood samples were collected for three times, at the end of the 3-week diet, before the beginning of the second diet and at the end of their second diet. Plasma renin activity and aldosterone levels were measured in the blood samples collected. Aldosterone level was measured in the 24-hour urine in mentioned days.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Normal salt diet
The group had normal salt diet (250mmol)for three weeks. Subjects had normal salt diet in their daily routine life for the following 2 weeks.According to crossover nature of the study, the group had low salt diet (50mmol) at the last 3 weeks of the study.
No interventions assigned to this group
Low salt diet
The group had low salt diet (50mmol)for three weeks. Subjects had normal salt diet in their daily routine life for the following 2 weeks.According to crossover nature of the study, the group had normal salt diet at the last 3 weeks of the study.
Lowering salt in diet
Low salt diet (50mmol)for three weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lowering salt in diet
Low salt diet (50mmol)for three weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects whose systolic blood pressure is ≥ 140 mmHg
* Subjects whose diastolic blood pressure is ≥ 90 mmHg
* Subjects who is normal weighted defined as body mass index \< 25 or who is obese defined as body mass index \> 30
* Subjects who have intellectual capacity to adapt diets and 24 hour urine collection
* Informed about the study and consented to include the study
Exclusion Criteria
* Known renal failure
* Known chronic liver disease
* Antihypertensive drug use
* nonsteroidal anti inflammatory (NSAI) drug use
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Turkish Society of Hypertension and Renal Diseases
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mustafa Arici, Prof.
Role: PRINCIPAL_INVESTIGATOR
Hacettepe University Faculty of Medicine Department of Nephrology
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HT-Salt
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.